4//SEC Filing
Dananberg Jamie 4
Accession 0000899243-22-006454
CIK 0001463361other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:23 PM ET
Size
8.0 KB
Accession
0000899243-22-006454
Insider Transaction Report
Form 4
Dananberg Jamie
Chief Medical Officer
Transactions
- Award
Common Stock, $0.0001 par value
2022-02-09+45,833→ 705,530 total - Award
Stock Option (Right to Buy)
2022-02-09+183,333→ 183,333 totalExercise: $1.06Exp: 2032-02-09→ Common Stock (183,333 underlying)
Footnotes (3)
- [F1]Represents Restricted Stock Units ("RSUs") one third of which vests on February 9, 2023 with the remaining RSUs vesting in equal quarterly installments over a two year period thereafter. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
- [F2]Includes RSUs which vest over time measured from the grant date.
- [F3]The underlying shares vest and become exercisable pursuant to the following schedule: One Third of the shares subject to the option vest on February 9, 2023 (the "Vesting Commencement Date"), and the remaining shares subject to the option vest in 24 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001734424
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:23 PM ET
- Size
- 8.0 KB